| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Judy C Odom last filed a Form 4 in April 2023, as Director at SABR. The filings on record cover 3 companies. Judy C Odom's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 70,298 shares of LEG.
Judy C Odom has 34 Form 4 filings on record from January 2015 to April 2023, across 3 companies: Director at Leggett & Platt (LEG), 2023; Director at Sabre (SABR), 2016–2021; Director at Harte Hanks (HHS), 2015–2018.
The 36 reported transactions were 30 stock awards, 2 tax withholdings, 2 open-market purchases and 1 open-market sale, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 2 purchases worth about $121K and 1 sale worth about $248K.
The largest open-market purchase was 15,000 shares of HHS at an average $4.65 on August 6, 2015, about $70K.
The only open-market sale was 10,000 shares of SABR at an average $24.78 on October 4, 2018, about $248K.
Shares as reported in the last Form 4 for each company; the most recent is from April 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.